| RS2506500559 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2506500607 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2506500879 |
PALB2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2506500998 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2506501948 |
CLN3
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 3, Neuronal ceroid lipofuscinosis 3 |
| RS2506503909 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2506504746 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2506505884 |
PALB2
|
Health Risk |
Pathogenic |
Gastric cancer, Familial cancer of breast |
| RS2506505979 |
PALB2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2506506429 |
PALB2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2506506514 |
PALB2
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2506506605 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2506506863 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2506506942 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2506507300 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2506507383 |
CLN3
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS2506507642 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2506508888 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2506508979 |
PALB2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2506509176 |
PALB2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2506511810 |
PALB2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Familial cancer of breast |
| RS2506512121 |
PALB2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2506512269 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2506512755 |
SCNN1B
|
Health Risk |
Likely pathogenic |
Opsoclonus-myoclonus syndrome, Opsoclonus-myoclonus syndrome |
| RS2506513116 |
PALB2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2506513330 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2506513633 |
PALB2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2506514549 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2506514869 |
SCNN1B
|
Health Risk |
Pathogenic |
Liddle syndrome 1, Liddle syndrome 1 |
| RS2506514993 |
CYLD
|
Health Risk |
Pathogenic/Likely pathogenic |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 8, Frontotemporal dementia and/or amyotrophic lateral sclerosis 8 |
| RS2506515350 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2506515843 |
PALB2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2506516970 |
PALB2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2506517377 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2506518424 |
PALB2
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2506518476 |
PALB2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2506518601 |
PALB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2506519015 |
PALB2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2506519342 |
PALB2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2506527617 |
CLN3
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS2506529268 |
GNAO1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with involuntary movements, Neurodevelopmental disorder with involuntary movements |
| RS2506529308 |
GNAO1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 17 |
| RS2506529438 |
GNAO1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with involuntary movements, Developmental and epileptic encephalopathy |
| RS2506529497 |
GNAO1
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2506530490 |
CLN3
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis 3 |
| RS2506530720 |
CLN3
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS2506531670 |
GNAO1
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2506533604 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2506533950 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2506534070 |
PALB2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2506534790 |
PALB2
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2506535967 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2506536286 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2506536640 |
PALB2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2506539351 |
PALB2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2506539704 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2506539880 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2506539952 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2506540052 |
PALB2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2506540669 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2506540801 |
PALB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS2506564729 |
PHKB
|
Health Risk |
Pathogenic |
Glycogen storage disease IXb, Glycogen storage disease IXb |
| RS2506567176 |
PHKB
|
Health Risk |
Likely pathogenic |
Glycogen storage disease IXb, Glycogen storage disease IXb |
| RS2506567482 |
COG7
|
Health Risk |
Pathogenic |
COG7 congenital disorder of glycosylation, COG7 congenital disorder of glycosylation |
| RS2506568316 |
PALB2
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2506572115 |
PALB2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2506572642 |
PALB2
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2506572755 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2506572966 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2506573467 |
PHKB
|
Health Risk |
Pathogenic |
Glycogen storage disease IXb, Glycogen storage disease IXb |
| RS2506575006 |
OCA2
|
Health Risk |
Pathogenic |
— |
| RS2506575769 |
OCA2
|
Health Risk |
Likely pathogenic |
Tyrosinase-positive oculocutaneous albinism, Tyrosinase-positive oculocutaneous albinism |
| RS2506578179 |
MYH11
|
Health Risk |
Likely pathogenic |
Aortic aneurysm, familial thoracic 4 |
| RS2506584752 |
COG7
|
Health Risk |
Likely pathogenic |
COG7 congenital disorder of glycosylation, COG7 congenital disorder of glycosylation |
| RS2506592783 |
COG7
|
Health Risk |
Pathogenic |
COG7 congenital disorder of glycosylation, COG7 congenital disorder of glycosylation |
| RS2506593745 |
FANCI
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group I |
| RS2506599338 |
FANCI
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2506610275 |
PHKB
|
Health Risk |
Likely pathogenic |
Glycogen storage disease IXb, Glycogen storage disease IXb |
| RS2506610770 |
SRCAP
|
Health Risk |
Pathogenic |
— |
| RS2506612939 |
ANK2
|
Health Risk |
Pathogenic |
ANK2-associated Neurodevelopmental Disorder, ANK2-associated Neurodevelopmental Disorder |
| RS2506619664 |
COG7
|
Health Risk |
Likely pathogenic |
COG7 congenital disorder of glycosylation, COG7 congenital disorder of glycosylation |
| RS2506621905 |
PHKB
|
Health Risk |
Pathogenic |
Glycogen storage disease IXb, Glycogen storage disease IXb |
| RS2506624513 |
SRCAP
|
Health Risk |
Likely pathogenic |
Developmental delay, hypotonia |
| RS2506627905 |
SRCAP
|
Health Risk |
Pathogenic |
Floating-Harbor syndrome, Developmental delay |
| RS2506628039 |
SRCAP
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2506635538 |
SRCAP
|
Health Risk |
Likely pathogenic |
— |
| RS2506639430 |
COG7
|
Health Risk |
Pathogenic |
COG7 congenital disorder of glycosylation, COG7 congenital disorder of glycosylation |
| RS2506642569 |
COG7
|
Health Risk |
Likely pathogenic |
COG7 congenital disorder of glycosylation, COG7 congenital disorder of glycosylation |
| RS2506665187 |
SRCAP
|
Health Risk |
Likely pathogenic |
— |
| RS2506669408 |
SRCAP
|
Health Risk |
Likely pathogenic |
Developmental delay, hypotonia |
| RS2506673023 |
ARL6IP1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 61, Hereditary spastic paraplegia 61 |
| RS2506676388 |
LAT
|
Health Risk |
Pathogenic |
— |
| RS2506677149 |
SRCAP
|
Health Risk |
Likely pathogenic |
SRCAP-related disorder, SRCAP-related disorder |
| RS2506681723 |
LAT
|
Health Risk |
Pathogenic |
— |
| RS2506697045 |
SRCAP
|
Health Risk |
Pathogenic |
— |
| RS2506697053 |
SRCAP
|
Health Risk |
Pathogenic |
Developmental delay, hypotonia |
| RS2506702087 |
RBL2
|
Health Risk |
Likely pathogenic |
Brunet-Wagner neurodevelopmental syndrome, Brunet-Wagner neurodevelopmental syndrome |
| RS2506716542 |
CYLD
|
Health Risk |
Pathogenic |
Familial cylindromatosis, Familial cylindromatosis |
| RS2506722059 |
PHKB
|
Health Risk |
Pathogenic |
Glycogen storage disease IXb, Glycogen storage disease IXb |
| RS2506722312 |
PHKB
|
Health Risk |
Pathogenic |
Glycogen storage disease IXb, Glycogen storage disease IXb |